Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.

Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a new revision label (v3.6.4) and removes some related-topic entries, representing a housekeeping update to the page’s metadata and links.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew topic metadata was added to the page, including Melanoma. A related topics section now lists MedlinePlus Genetics.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded Revision: v3.6.3. Removed related topics: Melanoma, MedlinePlus Genetics, and Revision: v3.6.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page displays a new revision tag 'Revision: v3.6.2' replacing 'v3.6.0', indicating a newer version of the page was published, with no substantive changes to the study data.SummaryDifference0.1%

- Check45 days agoChange DetectedThe condition label 'Melanoma' and the related topics section including 'MedlinePlus Genetics' have been removed from the study details, reducing explicit disease context and access to patient-oriented resources.SummaryDifference0.2%

- Check52 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' signaling the study is not enrolling. The page adds new help sections and standardizes the Intervention/Treatment label, with a site revision to v3.6.0.SummaryDifference0.6%

Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.